Gastroesophageal cancer Header
opdivo-dtc-util-nav

Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user hosing down surfboards on the beach.
Potential OPDIVO® (nivolumab) user hosing down surfboards on the beach.

Clinical trial results for
gastric (stomach),
gastroesophageal junction,
or esophageal cancers

See results for OPDIVO immunotherapy, alone or in combination with other therapies

Actor portrayal.

Advanced gastroesophageal cancer

OPDIVO with chemotherapy

For certain adults with previously untreated advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma

Advanced esophageal squamous cell cancer

OPDIVO with chemotherapy

For certain adults with previously untreated advanced or metastatic esophageal squamous cell cancer

Advanced esophageal squamous cell cancer

OPDIVO + YERVOY

For certain adults with previously untreated advanced or metastatic esophageal squamous cell cancer

Esophageal or gastroesophageal junction cancer after surgery

OPDIVO

For certain adults with esophageal or gastroesophageal junction (GEJ) cancer that has been treated with chemoradiation followed by surgery to help prevent it from coming back

Previously treated advanced esophageal squamous cell cancer

OPDIVO

For certain adults who have had prior chemotherapy for advanced esophageal squamous cell cancer

OPDIVO and OPDIVO-based combination treatments will not work for everyone. Individual results may vary.

Hands exploring how OPDIVO® (nivolumab) works and learning how this treatment may help fight cancer.

How treatment works

See how this treatment may help your body fight cancer

OPDIVO® (nivolumab) side effects.

Side effects

View side effects of treatment and learn how to manage them

Nurse monitoring a gentleman's infusion of OPDIVO® (nivolumab) immunotherapy treatment.

Getting an infusion

See your recommended treatment plan and what to expect from an infusion